flow trial semaglutide kidney outcomes hazard ratio 0.76 nejm 2024 in Patients with Obesity-Related Heart Failure and Type 2 Diabetes Kidney Outcomes With Glucagon-Like Peptide-1
Description
Heres what that means for semaglutide: Bioequivalence: For a generic drug to be FDA-approved, it must be bioequivalent to the brand-name drug
Understanding Your Nutritional Needs During illness, your bodys protein requirements actually increase to support immune system function and tissue repair
doi: 10.1210/clinem/dgaa202
Because you can't just throw a sort of set of generic lifestyle suggestions at people, but you really do need to be kind of more targeted about how to help this specific person fight that biological imperative
